Published on 05/12/2025
Best Practices for Combined & Companion QMS for Medical Devices & Combination Products in GxP and ISO-Certified Organizations
In the regulated environments of the pharmaceutical, biotech, and medical device industries, establishing a robust Quality Management System (QMS) is essential for ensuring compliance with regulatory requirements. This article provides a step-by-step tutorial on implementing a combined and companion QMS specifically tailored for medical devices and combination products. The focus will be on meeting the expectations set forth by the US FDA, EMA, and ISO standards.
Step 1: Understanding the Regulatory Framework
The first step in establishing
In the US, the FDA’s Combination Products guidance outlines the regulatory pathways for these products. In the UK and EU, similar regulations exist under the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR).
Objectives: Familiarize yourself with the applicable regulations and guidance documents for your products.
Documentation: Maintain a regulatory requirements matrix that outlines the specific regulations applicable to your products.
Roles: Quality managers should lead the effort to compile and disseminate this information to relevant stakeholders.
Inspection Expectations: Inspectors will expect to see a clear understanding of the regulatory landscape and how it informs your QMS.
Step 2: Defining the Scope of the QMS
Once the regulatory framework is understood, the next step is to define the scope of the QMS. This involves identifying the processes, products, and services that will be covered by the QMS. For combined and companion products, it is essential to consider the interactions between the different components of the product.
Objectives: Clearly define what is included in the QMS and what is excluded.
Documentation: Develop a scope document that outlines the boundaries of the QMS, including the types of products and processes involved.
Roles: Quality assurance teams should collaborate with product development and regulatory affairs to ensure all aspects are covered.
Inspection Expectations: Inspectors will review the scope document to ensure it aligns with the regulatory requirements and the organization’s operational capabilities.
Step 3: Developing QMS Policies and Procedures
The development of QMS policies and procedures is a critical step in ensuring compliance and operational efficiency. These documents should address all aspects of quality management, including design control, risk management, and post-market surveillance.
Objectives: Create comprehensive policies and procedures that align with regulatory requirements and industry best practices.
Documentation: Each policy should be documented and include a version control system to track changes over time.
Roles: Quality managers should lead the development of these documents, with input from cross-functional teams including R&D, manufacturing, and regulatory affairs.
Inspection Expectations: Inspectors will evaluate the adequacy and effectiveness of the policies and procedures during audits.
Step 4: Implementing Training Programs
Training is a vital component of a successful QMS. Employees must be adequately trained on the policies and procedures that govern their work, especially in regulated environments where compliance is critical.
Objectives: Ensure that all employees understand their roles and responsibilities within the QMS.
Documentation: Develop a training matrix that outlines required training for each role within the organization.
Roles: Quality managers should oversee the training program, while department heads are responsible for ensuring their teams are trained.
Inspection Expectations: Inspectors will review training records to verify that employees have received the necessary training and understand the QMS.
Step 5: Conducting Internal Audits
Internal audits are essential for assessing the effectiveness of the QMS and identifying areas for improvement. These audits should be planned and conducted regularly to ensure ongoing compliance with regulatory requirements.
Objectives: Identify non-conformities and areas for improvement within the QMS.
Documentation: Develop an internal audit plan that outlines the audit schedule, scope, and criteria.
Roles: Quality assurance teams should conduct the audits, while department heads should be responsible for addressing any findings.
Inspection Expectations: Inspectors will review audit reports and corrective action plans to ensure that non-conformities are addressed in a timely manner.
Step 6: Managing Corrective and Preventive Actions (CAPA)
Managing CAPA is a critical aspect of maintaining a compliant QMS. This process involves identifying, investigating, and addressing non-conformities to prevent recurrence.
Objectives: Establish a systematic approach to CAPA that addresses both corrective and preventive actions.
Documentation: Maintain a CAPA log that tracks all identified issues, investigations, and actions taken.
Roles: Quality managers should oversee the CAPA process, while cross-functional teams should participate in investigations and action implementation.
Inspection Expectations: Inspectors will review CAPA records to ensure that issues are being addressed appropriately and that preventive measures are in place.
Step 7: Monitoring and Measuring QMS Performance
Monitoring and measuring the performance of the QMS is essential for continuous improvement. This involves collecting data on key performance indicators (KPIs) and using this data to inform decision-making.
Objectives: Establish a framework for monitoring QMS performance and identifying trends.
Documentation: Develop a performance monitoring plan that outlines the KPIs to be measured and the methods for data collection.
Roles: Quality managers should lead the performance monitoring efforts, with input from various departments.
Inspection Expectations: Inspectors will expect to see evidence of performance monitoring and how it informs QMS improvements.
Step 8: Engaging with Regulatory Authorities
Engaging with regulatory authorities is crucial for maintaining compliance and staying informed about changes in regulations. This includes participating in industry forums, attending workshops, and maintaining open lines of communication with regulatory bodies.
Objectives: Build relationships with regulatory authorities to facilitate compliance and gain insights into regulatory changes.
Documentation: Keep records of communications with regulatory authorities and any relevant meetings or workshops attended.
Roles: Regulatory affairs professionals should take the lead in engaging with regulatory bodies.
Inspection Expectations: Inspectors may inquire about your organization’s engagement with regulatory authorities and how it informs your QMS.
Conclusion
Implementing a combined and companion QMS for medical devices and combination products requires a thorough understanding of regulatory requirements and a commitment to quality management principles. By following the steps outlined in this tutorial, organizations can establish a robust QMS that meets the expectations of the FDA, EMA, and ISO standards. Continuous improvement and proactive engagement with regulatory authorities will further enhance compliance and operational excellence.